leisure time -WSS

leisure time

author：explore 2025-09-30 16:59:52 - browse：1

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： A virus, fished out of a lake, may have saved a man’s life

WSS

Was Amgen transparent enough on FDA's concern on cancer drug?

RSV injection headlines need to be accurate for good uptake

Stop Congress from blocking public access to science

Why Charlie Gard's case is so disturbing to Americans

Why age limits for politicians are a terrible idea

CDC picks Alphabet's Verily for wasterwater surveillance contract

entertainment

leisure time

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Study points to new risk in gene therapy death of Terry Horgan

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Health insurers' Q3 question: how much care are people getting?

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

After affirmative action ruling, medical educators look to 'holistic review'

The United States is paying nearly triple for new Covid vaccines

Wildfire smoke exposes gaps in outdoor worker protections

Health insurers' Q3 question: how much care are people getting?

focus

Chan Zuckerberg Biohub Chicago to focus on inflammation

FDA panel signals lack of confidence in Amgen cancer drug data

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Some top drug companies are starting to take action on climate

Histogen: Failed biotech offers rare public look inside

CDC picks Alphabet's Verily for wasterwater surveillance contract

entertainment

focus

focus

focus